Induction of caspase 3 activity, bcl-2 bax and p65 gene expression modulationin human acute promyelocytic leukemia HL-60 cells by doxorubicin with amifostine.

Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 3

Abstract

The influence of amifostine alone and in combination with doxorubicin,cytarabine, and etoposide on the cell growth and on bcl-2, bax and p65 gene expression was investigatedin human acute promyelocytic leukemia cell line HL-60. No or very little influence of the exposure ofHL-60 cells to amifostine (10(-6) to 10(-2) M) on cell proliferation was shown. Proliferation of HL-60cells exposed to doxorubicin, cytarabine, or etoposide dropped down with increasing doses of these drugs.Only in the case of doxorubicin, more effective inhibition of HL-60 cell growth was observed when combinationof doxorubicin, cytarabine or etoposide with amifostine was used. Cytotoxic effect of cytarabine or etoposidewas not reduced by amifostine. The lowering of the cytotoxic index (IC(50)) was observed only when HL-60cells were preincubated with amifostine followed by doxorubicin treatment. IC(50) was estimated as 2.1x 10(-7) M and 0.9 x 10(-7) M for doxorubicin and doxorubicin with amifostine, respectively. This effectwas accompanied by the induction of caspase 3 activity. HL-60 cells treated with doxorubicin alone showedabout 35-fold increase in caspase 3 activity. The enzyme activity was stimulated by combination of doxorubicinwith amifostine up to 94 times. Furthermore, the expression of bcl-2 and bax genes involved in apoptosisas well as tumor-associated p65 gene were determined. Semiquantitative reverse transcriptase polymerasechain reaction showed a decrease in bcl-2 and an increase in bax and p65 expression in HL-60 cells treatedwith doxorubicin in combination with amifostine when compared with the cells treated only with doxorubicin.Amifostine may potentiate doxorubicin therapeutic efficiency in human acute promyelocytic leukemia cells.

Authors and Affiliations

Marek Różalski, Ewa Balcerczak, Urszula Krajewska, Wojciech Młynarski, Ryszard Wierzbicki

Keywords

Related Articles

Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen species.

While several studies have been conducted on the antioxidant properties of the beta-amino acid taurine, these studies all used concentrations lower than what is found physiologically. This study investigates the scavengi...

Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1.

Background: Expression of drug-metabolizing enzymes and drug transporters in liver is mainly regulated by a system of nuclear receptors. The aim of the current study was to investigate the expression of nuclear receptors...

Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia.

The aim of this study was to determine whether antineoplastic cytostatic therapy induces changes in the oxidation or acetylation phenotypes in patients with acute myeloblastic leukemia (AML). The investigations involved...

N-phenylmaleimide derivatives as mimetic agents of the pro-inflammatory process: myeloperoxidase activation.

Myeloperoxidase (MPO) is an important enzyme that catalyzes the reaction between hydrogen peroxide and chloride to generate hypochlorous acid, which oxidizes a range of biomolecules and has been associated with inflammat...

Amphetamine-induced anxiety-related behavior in animal models.

The purpose of this study was to examine the anxiety-related effects of acute and repeated amphetamine administration using the elevated plus maze (EPM) and light/dark box tests in mice. D-amphetamine (2 mg/kg ip, 30 min...

Download PDF file
  • EP ID EP128713
  • DOI -
  • Views 99
  • Downloads 0

How To Cite

Marek Różalski, Ewa Balcerczak, Urszula Krajewska, Wojciech Młynarski, Ryszard Wierzbicki (2005). Induction of caspase 3 activity, bcl-2 bax and p65 gene expression modulationin human acute promyelocytic leukemia HL-60 cells by doxorubicin with amifostine.. Pharmacological Reports, 57(3), 360-366. https://europub.co.uk/articles/-A-128713